quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:30:00·28d
PRRelease
Enlivex Ltd. logo

Enlivex Rain Update: Rain Launches an OpenClaw and AI Agent Interface Allowing Anyone To Create A Prediction Market Via A Single Prompt

ENLV· Enlivex Ltd.
Health Care
Original source

Companies

  • ENLV
    Enlivex Ltd.
    Health Care

Related

  • PR21h
    Enlivex to Present Phase IIa 3-month and 6-month Data of Allocetra at OARSI 2026 World Congress
  • SEC2d
    SEC Form F-3 filed by Enlivex Ltd.
  • SEC2d
    SEC Form 6-K filed by Enlivex Ltd.
  • PR2d
    Enlivex Announces Second Regulatory Approval for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
  • SEC15d
    SEC Form 6-K filed by Enlivex Ltd.
  • PR15d
    Ondo Global Markets Tokenizes Enlivex's Ordinary Shares
  • SEC28d
    SEC Form 6-K filed by Enlivex Ltd.
  • SEC29d
    SEC Form 20-F filed by Enlivex Ltd.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022